✦ LIBER ✦

Interim data on long-term efficacy, safety and tolerability of a plasma-derived factor VIII concentrate in 109 patients with severe haemophilia A

✍ Scribed by L. NEMES; H. POLLMANN; T. BECKER

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy, safety and tolerability of rec

✍ H. POLLMANN; D. EXTERNEST; A. GANSER; B. EIFRIG; W. KREUZ; H. LENK; I. PABINGER; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 487 KB

Clinical efficacy, safety and pharmacoki

✍ M. SERBAN; A. B. SKOTNICKI; M. COLOVIC; C. JINCA; A. KLUKOWSKA; P. LAGUNA; D. M. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 73 KB

Clinical efficacy, safety and pharmacoki

✍ D. M. Wolf; R. Rokicka-Milewska; S. Lopaciuk; A. B. Skotnicki; A. Klukowska; P. 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 101 KB

The safety and efficacy of B-domain dele

✍ J. M. Lusher; D. A. Roth 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 29 KB

A clinical study assessing the pharmacok

✍ T. LISSITCHKOV; M. MATYSIAK; K. ZAVILSKA; P. ŁAGUNA; L. GERCHEVA; A. ANTONOV; N. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 113 KB

Safety and efficacy of plasma-derived co

✍ D. V. K. QUON; L. LOGAN 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 195 KB